114 related articles for article (PubMed ID: 33112115)
21. Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung.
Awaya H; Takeshima Y; Yamasaki M; Inai K
Am J Clin Pathol; 2004 May; 121(5):644-53. PubMed ID: 15151204
[TBL] [Abstract][Full Text] [Related]
22. Ovarian mucinous tumour arising in mature cystic teratoma and associated with pseudomyxoma peritonei: report of two cases and comparison with ovarian involvement by low-grade appendiceal mucinous tumour.
Stewart CJ; Tsukamoto T; Cooke B; Leung YC; Hammond IG
Pathology; 2006 Dec; 38(6):534-8. PubMed ID: 17393980
[TBL] [Abstract][Full Text] [Related]
23. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall.
Gordetsky J; Epstein JI
Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma.
Wang HL; Lu DW; Yerian LM; Alsikafi N; Steinberg G; Hart J; Yang XJ
Am J Surg Pathol; 2001 Nov; 25(11):1380-7. PubMed ID: 11684954
[TBL] [Abstract][Full Text] [Related]
25. Mucins secreted by cell lines derived from colorectal mucinous carcinoma and adenocarcinoma.
Cho M; Dahiya R; Choi SR; Siddiki B; Yeh MM; Sleisenger MH; Kim YS
Eur J Cancer; 1997 May; 33(6):931-41. PubMed ID: 9291818
[TBL] [Abstract][Full Text] [Related]
26. GATA3 expression in benign prostate glands with radiation atypia: a diagnostic pitfall.
Tian W; Dorn D; Wei S; Sanders RD; Matoso A; Shah RB; Gordetsky J
Histopathology; 2017 Jul; 71(1):150-155. PubMed ID: 28316088
[TBL] [Abstract][Full Text] [Related]
27. Prostate-specific antigen, high-molecular-weight cytokeratin (clone 34betaE12), and/or p63: an optimal immunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma.
Kunju LP; Mehra R; Snyder M; Shah RB
Am J Clin Pathol; 2006 May; 125(5):675-81. PubMed ID: 16707367
[TBL] [Abstract][Full Text] [Related]
28. A case of mucin-producing urothelial-type adenocarcinoma of the prostate showing immunoreactivity for NKX3.1, a specific marker of prostatic tissue.
Kawasaki T; Saito T; Uchida K; Mio K; Nishida H; Homma K
Pathol Int; 2017 Sep; 67(9):483-484. PubMed ID: 28868747
[No Abstract] [Full Text] [Related]
29. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma.
Pinto-de-Sousa J; David L; Reis CA; Gomes R; Silva L; Pimenta A
Virchows Arch; 2002 Mar; 440(3):304-10. PubMed ID: 11889602
[TBL] [Abstract][Full Text] [Related]
30. Cytokeratin expression profiling in gastric carcinoma: clinicopathologic significance and comparison with tumor-associated molecules.
Takami H; Sentani K; Matsuda M; Oue N; Sakamoto N; Yasui W
Pathobiology; 2012; 79(3):154-61. PubMed ID: 22286119
[TBL] [Abstract][Full Text] [Related]
31. Urothelial-type adenocarcinoma of the prostate mimicking metastatic colorectal adenocarcinoma.
Adley BP; Maxwell K; Dalton DP; Yang XJ
Int Braz J Urol; 2006; 32(6):681-7; discussion 687-8. PubMed ID: 17201946
[TBL] [Abstract][Full Text] [Related]
32. Aberrant expression of the gastric mucin MUC6 in human pulmonary adenocarcinoma xenografts.
Hamamoto A; Abe Y; Nishi M; Fujimori S; Ohnishi Y; Yamazaki H; Oida Y; Miyazaki N; Inada K; Ueyama Y; Iwasaki M; Inoue H; Nakamura M
Int J Oncol; 2005 Apr; 26(4):891-6. PubMed ID: 15753982
[TBL] [Abstract][Full Text] [Related]
33. [Clinicopathological features of stratified mucin-producing neoplastic lesions of the cervix].
Xu H; Wang YM; Zhang J
Zhonghua Bing Li Xue Za Zhi; 2020 Jan; 49(1):28-33. PubMed ID: 31914531
[No Abstract] [Full Text] [Related]
34. [Mucinous adenocarcinoma of the prostate: a case report and review of 32 cases on immunohistochemical study of both PSA and CEA].
Furuta A; Naruoka T; Hasegawa N; Suzuki Y; Ikemoto I; Oishi Y
Nihon Hinyokika Gakkai Zasshi; 2003 Jul; 94(5):570-3. PubMed ID: 12910933
[TBL] [Abstract][Full Text] [Related]
35. Mucin-producing urothelial-type adenocarcinoma of the prostate diagnosed after robot-assisted radical prostatectomy.
Shimizu K; Inoue R; Tomochika S; Isoyama N; Yamamoto Y; Matsumoto H; Shiraishi K; Yoshino S; Tsuzuki T; Matsuyama H
IJU Case Rep; 2022 Jan; 5(1):32-35. PubMed ID: 35005467
[TBL] [Abstract][Full Text] [Related]
36. Skene's Glands Adenocarcinoma: A Series of 4 Cases.
Tregnago AC; Epstein JI
Am J Surg Pathol; 2018 Nov; 42(11):1513-1521. PubMed ID: 29901570
[TBL] [Abstract][Full Text] [Related]
37. [Metastatic lymph node collision of a prostatic adenocarcinoma and an urothelial carcinoma and review of the literature].
Junca A; Frouin E; Irani J; Fromont G; Levillain P
Ann Pathol; 2015 Dec; 35(6):496-501. PubMed ID: 26597142
[TBL] [Abstract][Full Text] [Related]
38. Differential diagnosis of bladder versus colorectal adenocarcinoma: keratin 7 and GATA3 positivity in nuclear ß-catenin-negative glandular tumours defines adenocarcinoma of the bladder.
Broede A; Oll M; Maurer A; Siegert S; Stoerkel S; Golz R; Schwamborn K; Veeck J; Knuechel R; Gaisa NT;
J Clin Pathol; 2016 Apr; 69(4):307-12. PubMed ID: 26463756
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical study of the expression of MUC6 mucin and co-expression of other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas.
Reis CA; David L; Carvalho F; Mandel U; de Bolós C; Mirgorodskaya E; Clausen H; Sobrinho-Simões M
J Histochem Cytochem; 2000 Mar; 48(3):377-88. PubMed ID: 10681391
[TBL] [Abstract][Full Text] [Related]
40. Performance of different prostate specific antibodies in the cytological diagnosis of metastatic prostate adenocarcinoma.
Jia L; Jiang Y; Michael CW
Diagn Cytopathol; 2017 Nov; 45(11):998-1004. PubMed ID: 28888085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
